Health benefits or advocated health benefits of long-chain (LC)n-3 PUFA are better known by medical doctors as well as by consumers, so that consumption increases. In addition, the development of aquaculture requires more fishmeal and fish oil. Humanisation of care of companion animals is also associated with addition of LCn-3 PUFA in pet foods. The risk of the increased demand for LCn-3 PUFA is the excess harvesting of natural sources, especially of marine origin (oily fishes, krill). In order to improve sustainability, alternative sources of LCn-3 PUFA have been developed. These alternative sources are: (a) terrestrial plants naturally or genetically enriched in stearidonic acid (SDA), which bypasses the first limiting step of (i.e. ∆6 desaturase) of the biosynthesis of LCn-3 PUFA; (b) single-cell oils rich in LCn-3 PUFA (microalgae,Escherichia coli) and krill. Currently, plants rich in SDA are expensive, metabolic engineering is unfavourably accepted by consumers in many countries, cultivation of microalgae is very expensive even though their ability (for some of them) to synthesise biofuels could induce a decrease in industrial costs, and Antarctic krill harvest must be restricted. Thus, it is difficult to predict their real development in the future.
The digestive system of poultry breeders is highly solicited, especially late in the egg production period when the demand in lipids for yolk development increases. To maintain a good health status and optimal levels of egg production, the digestive system needs to be properly drained and stimulated. This study assesses the impact of the product DigestSea ® containing a sulphated polysaccharide extracted from green seaweeds named MSP ® LIPIDS , on liver physiology and laying performance of breeding turkeys in comparison with a choline and sorbitol complex. The trial was performed in two buildings, from 23 to 28 weeks of laying. One group of 2,016 turkey breeders received the choline and sorbitol complex at 1 L/1,000 L of drinking water while the test group of 2,110 turkey breeders received DigestSea ® at a dosage of 0.5 L/1,000 L of drinking water, during 2 periods, first 10 days at 23 weeks of laying and again 5 days at 27 weeks of laying. Histological evaluation of the liver was performed at the end of the trial. The results show higher egg production in the DigestSea ® group with a significant reduction of the biliary canal hyperplasia and blood capillaries leucocytosis in the portal area, associated with a statistically significant reduction of lipids overload in the liver. Overall, our results show that the use of DigestSea ® containing MSP ® LIPIDS helps maintain a high level of egg production and lower hepatic steatosis. In conclusion, the use of the product containing MSP ® LIPIDS in breeding poultry production may be beneficial to maintain animal health and production levels. Further experiments are required to determine the mechanisms of action as a reduction of lipid resorption, metabolic changes, and an increased energy demand due to improving egg production.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.